☆ 4.4 Letter

Correction of IVS I-110(G>A) β-thalassemia by CRISPR/Cas- and TALEN-mediated disruption of aberrant regulatory elements in human hematopoietic stem and progenitor cells

HAEMATOLOGICA (2019)

Get Full Text
Add to Collection

Journal

HAEMATOLOGICA
Volume 104, Issue 11, Pages E497-E501

Publisher

FERRATA STORTI FOUNDATION
DOI: 10.3324/haematol.2018.215178

Keywords

-

Categories

Hematology

Funding

  1. Republic of Cyprus through the Research Promotion Foundation [YFEIA/BIOSigma/0311(BE)/20]
  2. Cyprus Institute of Neurology and Genetics
  3. TELETHON of Cyprus
  4. Eurobank Cyprus Ltd [33173114]
  5. European Union [306201]
  6. German Federal Ministry of Education and Research [BMBF-01EO0803]
  7. Hellenic Society of Gene Therapy and Regenerative Medicine

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.